miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1
Dewei Peng,1,2 Jing Dong,1,2 Yunping Zhao,1,2 Xiaomei Peng,1,2 Jingjing Tang,1,2 Xiaoyan Chen,1,2 Lihua Wang,1,2 Dan-Ning Hu,2,3 Peter S Reinach,1,2 Jia Qu,1,2 Dongsheng Yan1,21School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical ...
Peng X +10 more
core
ZEB1 and Uveal Melanoma Invasiveness. [PDF]
Zhilnikova M +10 more
europepmc +1 more source
Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells. [PDF]
Narayana RVL +3 more
europepmc +1 more source
Independent validation of time to treatment as a prognostic factor in uveal melanoma. [PDF]
Moghadam A +4 more
europepmc +1 more source
Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. [PDF]
Yang K, Wu D.
europepmc +1 more source
Descemet membrane endothelial keratoplasty in patients after radiation therapy for uveal melanoma. [PDF]
Maier AB +6 more
europepmc +1 more source
Clonal determinants of organotropism and survival in metastatic uveal melanoma. [PDF]
Jones BSCL +11 more
europepmc +1 more source
Immunoembolization in liver-predominant metastatic uveal melanoma: a single-center retrospective analysis. [PDF]
Morecroft R +8 more
europepmc +1 more source
Comparative efficacy of therapeutic modalities for metastatic uveal melanoma: a systemic review and network meta-analysis. [PDF]
Chen Q, Zhou J, Zhou H, Wang H, Li J.
europepmc +1 more source
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. [PDF]
Piperno-Neumann S +31 more
europepmc +1 more source

